EUVIMEDEUVIMED entdecken
Open Access

Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing Fentanyl

Carly Baehr iD, Rajwana Jahan, Ann Gebo, Jennifer Vigliaturo, Daihyun Song iD, Md Toufiqur Rahman iD, Davide Tronconi iD, Aaron Khaimraj iD, Robert Seaman, Courtney Marecki, Caroline M Kim, Stefano Persano und 2 weitere

Bioconjugate Chemistry · 2025

DOI: 10.1021/acs.bioconjchem.4c00548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Carly Baehr und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Fentanyl, Haptens, Vaccines, Conjugate, Analgesics, Opioid. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasingly, street mixtures of opioids are reported to contain combinations of synthetic opioids, such as fentanyl with fentanyl analogues or counterfeit oxycodone pills containing fentanyl. While antiopioid immunotherapeutics have been investigated as a possible approach to address the opioid epidemic, the efficacy of vaccines and antibodies is limited to specific target opioids, based on the chemical structure of the haptens used in vaccines. Hence, there is a need for rational design of antiopioid conjugate vaccines that simultaneously target multiple opioids. Here, four novel haptens were synthesized, which were designed to elicit antibodies capable of binding to fentanyl other target opioids, including carfentanil, alfentanil, or oxycodone. Haptens were conjugated to CRM carrier protein and formulated with an aluminum salt adjuvant, and vaccines containing bivalent haptens were compared to admixtures of individual conjugate vaccines targeting the two opioids separately. Rats were immunized with monovalent, admixed, or novel bivalent vaccines, and the blockade of opioid effects was assessed against the individual drugs and their mixtures. Opioid-specific antibody titer was measured, and in vivo effects of vaccines were assessed in terms of preventing opioid-induced antinociception and respiratory depression and opioid distribution to the brain. While the bivalent vaccines reduced the effects of some target opioids, the admixed vaccine formulations were more effective against fentanyl/carfentanil and fentanyl/alfentanil mixtures. The bivalent fentanyl/oxycodone vaccine was as effective as the monovalent vaccines against a single drug challenge. These results inform the design of future vaccines against opioids and other drugs, particularly in the context of vaccines against polysubstance use that require optimization of response against multiple drugs of interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylHaptensVaccines, ConjugateAnalgesics, OpioidAnimalsRatsMaleRats, Sprague-DawleyOxycodone

Substanzen

FentanylHaptensVaccines, ConjugateAnalgesics, OpioidOxycodone

Autor:innen und Institutionen

  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
  • RTI International, Research Triangle Park, North Carolina 27709, United States.
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98104, United States.
  • Università degli Studi di Milano, Milano 20122, Italy.
  • Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98104, United States.
  • Garvey Institute for Brain Health Solutions, Seattle, Washington 98104, United States.

ORCID-Profile: Carly Baehr, Daihyun Song, Md Toufiqur Rahman, Davide Tronconi, Aaron Khaimraj

Förderung

  • NIDA NIH HHS
  • U.S. Department of Health and Human Services

Zitieren

APA

Baehr, C., Jahan, R., Gebo, A., Vigliaturo, J., Song, D., Rahman, M. T., Tronconi, D., Khaimraj, A., Seaman, R., Marecki, C., Kim, C. M., Persano, S., Runyon, S. P., & Pravetoni, M. (2025). Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing Fentanyl. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00548

Vancouver

Baehr C, Jahan R, Gebo A, Vigliaturo J, Song D, Rahman MT, et al. Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing Fentanyl. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.4c00548

BibTeX
@article{Baehr2025,
  author = {Baehr, Carly and Jahan, Rajwana and Gebo, Ann and Vigliaturo, Jennifer and Song, Daihyun and Rahman, Md Toufiqur and Tronconi, Davide and Khaimraj, Aaron and Seaman, Robert and Marecki, Courtney and Kim, Caroline M and Persano, Stefano and Runyon, Scott P and Pravetoni, Marco},
  title = {Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing Fentanyl},
  journal = {Bioconjugate Chemistry},
  year = {2025},
  doi = {10.1021/acs.bioconjchem.4c00548}
}
Kostenlos starten →